Williams Jones Wealth Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Williams Jones Wealth Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-178,485	Closed	-$2.06M	–	486
2020 Q3	$2.06M	Buy	178,485 +56,719	+47%	+$936K	0.04%	161
2020 Q2	$2.95M	Buy	121,766 +93,280	+327%	+$1.54M	0.06%	138
2020 Q1	$314K	Sell	28,486 -224,187	-89%	-$4.19M	0.01%	288
2019 Q4	$6.68M	Buy	252,673 +16,912	+7%	+$396K	0.13%	102
2019 Q3	$5.37M	Buy	+235,761	New	+$7.43M	0.11%	113

Other funds holding GTHX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Williams Jones Wealth Management's GTHX Position: Q4 2020 in Review

Williams Jones Wealth Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2020, closing a stake of 178,485 shares — an estimated $2.06M sold.

Williams Jones Wealth Management first reported a position in GTHX in Q3 2019 and held it in 5 quarters. The position peaked at $6.68M in Q4 2019. 125 funds tracked by Wall St. Rank hold GTHX as of Q4 2020.

Williams Jones Wealth Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Williams Jones Wealth Management sold 178,485 G1 Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $2.06M.
Williams Jones Wealth Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Williams Jones Wealth Management's G1 Therapeutics, Inc. Common Stock position peaked at $6.68M in Q4 2019.
125 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Williams Jones Wealth Management's 13F filing for Q4 2020, filed 16 Feb 2021.